Sign in or register to see full information and data.

Studies / CAVD 535


Study information

Grant Affiliation:Frank: Studies to Maximize Immunogenicity
Strategy:Protein & peptide vaccines
Study Type:Pre-Clinical Non-NHP
Species:Guinea Pig
Stage:Assays Completed
Study Start Date:2015-12-15
Study Made Public:2016-10-31


Studies to maximize immunogenicity by Env trimer stabilization and complement activation


CAVD 535 is pre-clinical guinea pig study evaluating neutralizing antibodies following BG505 SOSOIP gp140 and JRFL gp140 protein regimens.


B-glucan JRFL gp140 BG505 SOSIP - crosslinker BG505 SOSIP - crosslinker/glycosidase JRFL gp140 - crosslinker

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.